Innovating.works Conecta tu I+D

EFFECT: A European Training Program to Foster the Full Therapeutic Potential of Antisense Technology across... "The EFFecT Doctoral Training (DN) Network responds to the evolving landscape of RNA-based therapeutics and in particular antisense oligonuc...
2024-07-05 - 2028-12-31 | financed

ChimSep: Chemistry improvement thanks to Separation by membrane processes INSTITUT DE RECHERCHES SERVIER participó en un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 Two of the major hurdles for the chemical industry transition toward the chemical factory of the future are the ability to design (i) effici...
2023-07-06 - 2027-08-31 | financed

FACILITATE: FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical eco... INSTITUT DE RECHERCHES SERVIER participó en un H2020: H2020-JTI-IMI2-2020-23-two-stage FACILITATE is a project built on a patient-centered, data-driven, technological platform where an innovative data sharing and re-use process...
2021-10-11 - 2025-12-31 | financed

CARE: Corona Accelerated R D in Europe INSTITUT DE RECHERCHES SERVIER participó en un H2020: H2020-JTI-IMI2-2020-21-single-stage The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) pandemic has emerged as the largest global health threat to humanity in thi...
2020-08-07 - 2025-03-31 | financed

EUbOPEN: EUbOPEN Enabling and Unlocking biology in the OPEN INSTITUT DE RECHERCHES SERVIER participó en un H2020: H2020-JTI-IMI2-2019-17-two-stage The EUbOPEN partnership of excellence will aim to generate the largest freely available set of high-quality chemical inhibitors for human pr...
2020-05-11 - 2025-04-30 | financed

imSAVAR: Immune Safety Avatar nonclinical mimicking of the immune system effects of immunomodulatory therapi... INSTITUT DE RECHERCHES SERVIER participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage The vision of Immune Safety Avatar (imSAVAR) is to develop a platform for integrated nonclinical assessments of immunomodulatory therapy saf...
2019-11-18 - 2025-11-30 | financed

ZENITH: ZEbrafish Neuroscience Interdisciplinary Training Hub INSTITUT DE RECHERCHES SERVIER participó en un H2020: H2020-MSCA-ITN-2018 A fundamental challenge for Neuroscience is to understand how neural circuits process information from the outside world and internal physio...
2019-11-18 - 2024-03-31 | financed

MELLODDY: MachinE Learning Ledger Orchestration for Drug DiscoverY INSTITUT DE RECHERCHES SERVIER participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage MELLODDY will demonstrate how the pharmaceutical industry can better leverage its data assets to virtualize the Drug Discovery (DD) process...
2019-05-22 - 2022-05-31 | financed

EBiSC2: EBiSC2 A sustainable European Bank for induced pluripotent Stem Cells INSTITUT DE RECHERCHES SERVIER participó en un H2020: H2020-JTI-IMI2-2017-13-two-stage EBiSC2 builds on the achievements of the European Bank for iPSCs (EBiSC1) in centralising existing capacities across Europe in a unique bank...
2019-02-28 - 2023-02-28 | financed

ESCulab: European Screening Centre Unique Library for Attractive Biology INSTITUT DE RECHERCHES SERVIER participó en un H2020: H2020-JTI-IMI2-2017-12-two-stage By bridging an important gap between basic research and drug development, ESCulab will facilitate the translation of fundamental scientific...
2018-12-18 - 2023-11-30 | financed

EQIPD: European Quality In Preclinical Data INSTITUT DE RECHERCHES SERVIER participó en un H2020: H2020-JTI-IMI2-2016-09-two-stage Pharmaceutical industry, as well as basic science, depend on robust data and scientific rigor as key drivers for decision making, patent str...
2017-08-18 - 2021-09-30 | financed

ITCC-P4: ITCC Pediatric Preclinical POC Platform Sofia ref. 116064 INSTITUT DE RECHERCHES SERVIER participó en un H2020: H2020-JTI-IMI2-2015-07-two-stage Cancer remains the leading cause of disease-related death in children. For the ~25% of children who experience relapses of their malignant s...
2017-05-18 - 2023-12-31 | financed

IMPRiND: Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases Sofia ref. 116060 INSTITUT DE RECHERCHES SERVIER participó en un H2020: H2020-JTI-IMI2-2015-07-two-stage Assemblies of tau and α-synuclein were shown to spread along interconnected neuronal networks suggesting broadly relevant therapeutic direct...
2017-04-07 - 2022-02-28 | financed

RHAPSODY: Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification S... INSTITUT DE RECHERCHES SERVIER participó en un H2020: H2020-JTI-IMI2-2015-03-two-stage The stated goal of RHAPSODY is to define a molecular taxonomy of type 2 diabetes mellitus (T2D) that will support patient segmentation, info...
2016-06-07 - 2021-09-30 | financed

FRAGNET: FRAGments training NETwork INSTITUT DE RECHERCHES SERVIER participó en un H2020: H2020-MSCA-ITN-2015 The promise of more efficient lead discovery is fuelling the enthusiasm for fragment-based lead discovery (FBLD). In this approach, highly s...
2015-08-11 - 2020-02-29 | financed

IC-3i-PhD: Institut Curie 3 i PhD Program INSTITUT DE RECHERCHES SERVIER participó en un H2020: H2020-MSCA-COFUND-2014 The new IC-3i-PhD program of Institut Curie and its partners will produce top-level scientific knowledge by promoting basic interdisciplinar...
2015-05-13 - 2022-08-31 | financed